Eric Auger, Partner, was a recent speaker at the European Society of Gene & Cell Therapy Annual Congress held in collaboration with ISSCR and SFTCG, in Lausanne, Switzerland on October 16th-19th. The Congress brings together scientists, commercial leaders, business development professionals and investors working in the fields of gene and cell therapy from throughout Europe and beyond. Eric was an invited panelist for the Congress’ Clinical Development and Commercialization Workshop and spoke on the topic of pricing and market access for gene and cell therapies in the US market, leveraging Putnam’s deep experience supporting pioneering CART and gene therapy commercial launches.
In addition to Eric, the invited speakers on the panel included:
- Ron Philip, Spark Therapeutics, Philadelphia, PA
- Ilona Reischl, Federal Office for Safety in Health Care, Vienna
- Martina Schüssler-Lenz, Paul Ehrlich Institute, Langen
- Michela Gabaldo ,Telethon, Milan